Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

U.S. drug industry hopes China deal ends stealth attack on IP

Innovators hope trade deal stops China's stealth war on IP

December 21, 2019 2:39 AM UTC

Innovator pharmaceutical manufacturers hope the new “phase one” U.S.-China trade deal will create a cease-fire in the stealth war on pharma IP in China.

The deal, announced Dec. 13, comes at the end of a year when Chinese IP practices have cut short patent exclusivity for at least five innovative drugs...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article